Patient Leaflet Updated 04-Nov-2025 | Reig Jofre UK Ltd
Cefuroxime powder for solution for injection 1.5g and 750mg
Cefuroxime 750 mg Powder for Solution for Injection
Cefuroxime 1.5 g Powder for Solution for Injection or Infusion
(cefuroxime sodium)
1. What Cefuroxime injection is and what it is used for
2. What you need to know before you are given Cefuroxime injection
3. How Cefuroxime injection is given
4. Possible side effects
5. How to store Cefuroxime injection
6. Contents of the pack and other information
The name of your medicine is Cefuroxime 750 mg Powder for Injection or Cefuroxime 1.5 g Powder for Injection or Infusion but both will be referred to as Cefuroxime injection throughout this leaflet.
Cefuroxime injection contains cefuroxime, which is an antibiotic used in adults and children. It works by killing bacteria that cause infections. It belongs to a group of medicines called cephalosporins.
Cefuroxime injection is used to treat infections of:
Your doctor may also give it to you before an operation to protect you from infection. Your doctor may test the type of bacteria causing your infection and monitor whether the bacteria are sensitive to cefuroxime during your treatment.
Your doctor or nurse will make sure it is safe for you to have Cefuroxime injection.
Tell your doctor before you start on Cefuroxime injection if you think that this applies to you. You must not be given Cefuroxime injection.
You must look out for certain symptoms such as allergic reactions, skin rashes, gastrointestinal disorders such as diarrhoea and fungal infections while you are being given Cefuroxime injection. See (‘Conditions you need to look out for’) in section 4. You must tell your doctor or nurse if you develop any of these conditions.
If you have had any allergic reaction to other antibiotics such as penicillin, you may also be allergic to Cefuroxime injection.
Serious skin reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS) have been reported in association with cefuroxime treatment. Seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
This medicine can affect the results of tests for sugar in your urine or blood, and a blood test known as the Coombs test. If you are having tests it is important to tell the doctor and the person taking the sample(s) that you have been given this medicine.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Some medicines may affect how Cefuroxime injection works, or make it more likely that you will have side effects. These medicines include:
Tell your doctor if this applies to you. You may need extra monitoring while you are being given Cefuroxime injection.
Cefuroxime injection may reduce the effectiveness of the contraceptive pill. If you are taking the contraceptive pill while you are being treated with Cefuroxime injection you also need to use a barrier method of contraception (such as a condom). Ask your doctor for advice.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, tell your doctor before you are given this medicine.
Your doctor will consider the benefit of treating you with Cefuroxime injection against the risk to your baby.
Cefuroxime injection is unlikely to affect your ability to drive or operate machinery but do not drive or use machines if you feel unwell.
Cefuroxime injection contains sodium (the main component of cooking/table salt).
Each 750 mg vial contains 41 mg sodium. This is equivalent to 2% of the recommended maximum daily dietary intake of sodium for an adult.
Each 1.5 g vial contains 81 mg sodium. This is equivalent to 4% of the recommended maximum daily dietary intake of sodium for an adult.
Your doctor will decide which dose you need. Your doctor or nurse will inject the Cefuroxime injection into a muscle or into a vein. In some cases, it may be added to a ‘drip’ intravenous infusion.
The correct dose of Cefuroxime injection for you will be decided by your doctor and will depend on the severity and type of your infection, whether you are on any other antibiotics, your weight and age, how well your kidneys are working.
Adults and adolescents are usually given 750 mg to 1.5 g of cefuroxime two, three or four times daily. The maximum dose is 6 g per day. If you have kidney trouble, you may be given a lower dose.
Your doctor may give you 1.5 g of Cefuroxime injection before surgery to protect you from infection. You may receive further doses of 750 mg of Cefuroxime injection after the operation.
Babies (over 3 weeks) and children will usually be given 30 to 100 mg for each kilogram of their body weight each day. This will be divided into three or four doses.
Newborn babies (0-3 weeks) will usually be given 30 to 100 mg for each kilogram of their body weight each day. This will be divided into two or three doses.
It is most unlikely that you will be given too much medicine by the nurse or doctor. Your doctor and nurse will be monitoring your progress, and checking the medicine that you are given. However, always ask if you are not sure why you are getting a dose of medicine.
Your doctor or nurse have instructions when to give you your medicine. It is unlikely that you will not be given the medicine as it has been prescribed. However, if you think you may have missed a dose, talk to your nurse or doctor. It is important that the course of treatment your doctor has prescribed is given. You may start to feel better but it is important not to stop this medicine until the doctor advises, otherwise your condition may get worse again.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some people given cefuroxime may get an allergic reaction or potentially serious skin reaction. Tell a doctor or nurse immediately if you get any of the following symptoms:
Other symptoms you need to be aware of while being given cefuroxime include:
Tell your doctor or nurse if you get any of these symptoms.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Not known (frequency cannot be estimated from the available data):
The following side effects have occurred but their exact frequency is unknown:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
The un-opened dry powder should be stored below 25ºC, in the original package.
The doctor, pharmacist or nurse will make up your medicine. From a microbiological point of view, the reconstituted solution should be used immediately. If not used immediately, the reconstituted solution should be stored at 2-8ºC for no longer than 24 hours.
This medicine must not be used after the expiry date which is stated on the label and carton after ‘EXP’. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is cefuroxime sodium. There are no other ingredients.
Cefuroxime 750 mg powder for injection is a white or off-white powder which forms:
Cefuroxime 1.5 g powder for injection or infusion is a white or off-white powder which forms:
Cefuroxime 750 mg powder for injection is available in 10 ml vials in packs of 1, 5, 10 or 100 vials.
Cefuroxime 1.5 g powder for injection or infusion is available in 20 and 100 ml vials in packs of 1, 10 or 20 vials.
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
Manufacturer:
This leaflet was last revised in 10/2025
Follaton House, Plymouth Road, Totnes, Devon, TQ9 5NE, UK
0330 1359 434
01803 300401
01803 300401
www.reigjofre.com/en